Bone Disease and Multiple Myeloma

Bone disease is a serious complication of multiple myeloma. It affects over 80% of patients. It causes: 

• Lytic lesions (holes in the bone)
• Severe bone pain
• High risk of fractures

Bone pain is often one of the first symptoms of multiple myeloma. 

How does multiple myeloma cause bone disease

Multiple myeloma is a cancer that affects plasma cells. These are a type of white blood cell that are formed in the bone marrow. Bone marrow is the spongy tissue inside large bones where blood cells are made.

Bone disease happens when myeloma cells disrupt the bone-building cycle. This overactivates the cells that destroy bone, called osteoclasts. It also stops cells that build new bones, called osteoblasts. Because of this cycle, bones break down faster, and there is less new bone to replace them. 

When this happens, it is called multiple myeloma bone disease or MBD.

What are the key characteristics of myeloma bone disease?

The key characteristics of myeloma bone disease include: 

Osteolytic lesions (holes). Myeloma cells produce factors that eat away at the bone, creating holes. These are often visible on an x-ray.

Weakened bone structure. The bone breakdown causes severe osteoporosis, loss of bone density, and stability.

Commonly affected areas. The spine, ribs, pelvis, and skull are most often affected. 

What are the common complications of myeloma bone disease?

The common problems associated with myeloma bone disease include: 

Fractures: Bones break easily, even during normal, daily activities.

Severe Bone Pain: Especially in the back and the ribs.

Spinal Cord Compression: A serious condition that causes pain and paralysis.

Hypercalcemia: Extra calcium is released into the blood from damaged bones, causing confusion, fatigue, and kidney issues.

Damage: Multiple myeloma cells collect in the bone marrow where they speed up the activation of osteoclasts (bone destroying) and simultaneously stop osteoblasts (bone building) from repairing the damage.

How is myeloma bone disease diagnosed?

Bone lesions can be difficult to diagnose in the early stages of the disease, such as smoldering myeloma or MGUS. But there are scans to help detect bone disease. They find weak areas, fractures, and bone tumors. These scans include: 

• Low-dose whole-body CT (WBCT): This test is preferred over a standard X-ray to detect small lesions and damage to the bone structure.
• PET/CT Scan: This scan is a powerful, combined imaging test that combines a PET and CT scan to find bone disease in its early stages.
• MRI Scan: This test is best for finding soft tissue involvement, bone marrow infiltration, and focal lesions. It can also be used to discover spinal cord compression. 
• X-rays: These scans can view larger bones, but targeted PET and CT scans are more comprehensive.

General bone scans are not as useful for diagnosing myeloma bone disease. Bone marrow biopsies confirm the presence of plasma cells in the marrow that can cause bone damage. Blood and urine tests measure high levels of calcium (due to bone breakdown) and M-protein, which can help diagnose active multiple myeloma. 

How is myeloma bone disease managed and treated?

Myeloma bone disease is managed by combining anti-myeloma treatments (such as proteasome inhibitors, immunomodulatory drugs, and stem cell transplants) with bone-strengthening agents, such as bisphosphonates (Zometa, Aredia) or denosumab (Xgeva). These therapies help with bone breaking and pain.

Treatment Options

• Bisphosphonates: Zoledronic acid (Zometa) and pamidronate (Aredia) are used as a standard to slow down bone destruction. The FDA-approved drug denosumab (Xgeva) is often preferred, particularly for patients with existing kidney issues.

• Anti-Myeloma Therapy: Targeting myeloma directly reduces bone-damaging cells. This includes proteasome inhibitors (Velcade), which can assist with bone growth, immunomodulatory medications (Revlimid) that alter the immune system, and stem cell transplants.

• Radiation Therapy: Used for localized pain relief and to stabilize specific and severe bone lesions.

• Surgical Options: Procedures such as kyphoplasty or vertebroplasty are used to stabilize spinal fractures and relieve pain.

• Pain Management: Pain killers are crucial for managing bone pain.

Management Strategies

• Monitoring: Regular tests such as X-rays, MRIs, and PET scans track bone damage.

• Kidney Health: Monitoring kidney function is vital. It affects the choice of bone-strengthening medications.

• Lifestyle: Regular, safe exercise helps maintain bone density. Quitting smoking is advised to reduce bone loss.

• Nutrition and Supplements: Diets that incorporate vitamin D and calcium can help maintain bone health. Examples of foods that have these nutrients include leafy greens and dairy. 

Bone disease is a common but challenging complication of multiple myeloma. More than 80% of patients suffer from bone lesions leading to pain, fractures, spinal compression, and mobility issues. 

Although this disease can seriously impact the quality of life, advancements in imaging, treatment, and supportive care have improved outcomes for many patients. Early detection and immediate treatment are essential in slowing bone damage, reducing pain, and preventing serious complications. By combining anti-myeloma therapies, bone-strengthening medications, healthy lifestyle choices, and continuous monitoring, patients can better manage symptoms and experience a better quality of life.